Under the Umbrella of Clinical Pharmacology: Inflammatory Bowel Disease, Infliximab and Adalimumab, and a Bridge to an Era of Biosimilars
AuthID
P-00X-8A8
P-00X-8A8
© 2024 CRACS & Inesc TEC - All Rights Reserved Política de Privacidade | Terms of Service